• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素的代谢

Metabolism of vasopressin.

作者信息

Share L, Kimura T, Matsui K, Shade R E, Crofton J T

出版信息

Fed Proc. 1985 Jan;44(1 Pt 1):59-61.

PMID:3967770
Abstract

The clearance of vasopressin (VP) by the kidneys and splanchnic viscera was studied in the anesthetized dog. VP is bound to plasma protein, 10% at basal plasma VP levels and 40% at plasma VP concentrations greater than 20 microU/ml. The urinary clearance of VP is 70-100% of the glomerular filtration rate; the renal organ clearance of the hormone is 20-30% greater than its urinary clearance. There is evidence that the renal organ clearance of VP is affected by changes in both glomerular filtration rate and renal blood flow. The renal clearance of VP is a result of glomerular filtration, degradation, or reabsorption in the proximal nephron, and secretion into the distal nephron. In the short term, the renal clearance of VP is unaffected either by changes in the plasma VP concentration over a broad range or by moderate hemorrhage. The splanchnic clearance of VP is accomplished almost equally by the intestine and the liver. Because the sum of the splanchnic and renal clearances of VP is less than estimates of its metabolic clearance rate, there may be a physiologically significant clearance of VP by organs in addition to the kidneys and splanchnic viscera.

摘要

在麻醉犬身上研究了肾脏和内脏对血管加压素(VP)的清除情况。VP与血浆蛋白结合,基础血浆VP水平时结合率为10%,血浆VP浓度大于20微单位/毫升时结合率为40%。VP的尿清除率为肾小球滤过率的70 - 100%;该激素的肾脏器官清除率比其尿清除率高20 - 30%。有证据表明,VP的肾脏器官清除率受肾小球滤过率和肾血流量变化的影响。VP的肾脏清除是肾小球滤过、近端肾单位降解或重吸收以及向远端肾单位分泌的结果。短期内,VP的肾脏清除率不受血浆VP浓度在较宽范围内变化或中度出血的影响。VP的内脏清除几乎由肠道和肝脏平均完成。由于VP的内脏和肾脏清除率之和低于其代谢清除率的估计值,除肾脏和内脏外,其他器官可能对VP有生理意义的清除作用。

相似文献

1
Metabolism of vasopressin.血管加压素的代谢
Fed Proc. 1985 Jan;44(1 Pt 1):59-61.
2
Characterization of the renal handling of vasopressin in the dog by stop-flow analysis.通过停流分析法对犬抗利尿激素的肾脏处理进行表征。
Endocrinology. 1981 Dec;109(6):2089-94. doi: 10.1210/endo-109-6-2089.
3
Factors influencing urinary vasopressin concentration.影响尿血管加压素浓度的因素。
Fed Proc. 1985 Jan;44(1 Pt 1):62-5.
4
Effects of changes in steady state plasma vasopressin levels on renal and urinary vasopressin clearances in the dog.稳态血浆血管加压素水平变化对犬肾及尿中血管加压素清除率的影响。
Endocrinology. 1983 Jun;112(6):2107-13. doi: 10.1210/endo-112-6-2107.
5
Splanchnic clearance of plasma vasopressin in the dog: evidence for prehepatic extraction.
Am J Physiol. 1983 Dec;245(6):E611-5. doi: 10.1152/ajpendo.1983.245.6.E611.
6
Inter-organ leptin exchange in humans.人体器官间的瘦素交换
Biochem Biophys Res Commun. 1998 Jun 18;247(2):504-9. doi: 10.1006/bbrc.1998.8819.
7
Effects of nonhypotensive hemorrhage on renal organ and urinary clearances of vasopressin in the dog.非低血压性出血对犬肾器官及血管加压素尿清除率的影响。
Endocrinology. 1983 Jun;112(6):2114-9. doi: 10.1210/endo-112-6-2114.
8
Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients.低剂量血管加压素可提高心脏手术后患者的肾小球滤过率,但会损害其肾脏氧合。
Acta Anaesthesiol Scand. 2009 Sep;53(8):1052-9. doi: 10.1111/j.1399-6576.2009.02037.x. Epub 2009 Jun 30.
9
Mechanism of effect of prostaglandin E 1 on renal water excretion.前列腺素E1对肾脏水排泄的作用机制。
J Clin Invest. 1973 Feb;52(2):463-71. doi: 10.1172/JCI107203.
10
Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.3',5'-环磷酸腺苷及二丁酰3',5'-环磷酸腺苷对肾脏的影响。3',5'-环磷酸腺苷在近端肾小管钠重吸收调节中作用的证据。
J Clin Invest. 1971 Jun;50(6):1231-40. doi: 10.1172/JCI106600.

引用本文的文献

1
Validation of an integrative mathematical model of dehydration and rehydration in virtual humans.虚拟人体脱水与补液综合数学模型的验证
Physiol Rep. 2016 Nov;4(22). doi: 10.14814/phy2.13015.
2
Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.伴有和不伴有低钠血症的跑步者中copeptin 和生物活性血管加压素的变化。
Clin J Sport Med. 2011 May;21(3):211-7. doi: 10.1097/JSM.0b013e31821a62c2.
3
Oestrogen effects on urine concentrating response in young women.雌激素对年轻女性尿液浓缩反应的影响。
J Physiol. 2003 Nov 1;552(Pt 3):869-80. doi: 10.1113/jphysiol.2003.046920. Epub 2003 Aug 15.
4
Management of vasodilatory shock: defining the role of arginine vasopressin.血管舒张性休克的管理:确定精氨酸加压素的作用
Drugs. 2003;63(3):237-56. doi: 10.2165/00003495-200363030-00001.
5
Furosemide dynamics in conscious rabbits: modulation by arginine vasopressin.清醒家兔中呋塞米的动力学:精氨酸加压素的调节作用
Cardiovasc Drugs Ther. 1995 Apr;9(2):305-10. doi: 10.1007/BF00878675.